Wang Y, Peng X, Wang X, Chen J, Zheng X, Zhao X
Cell Biol Toxicol. 2025; 41(1):53.
PMID: 40014184
PMC: 11868302.
DOI: 10.1007/s10565-025-10000-2.
Mejecase C, Nair N, Sarkar H, Soro-Barrio P, Toms M, Halliday S
Antioxidants (Basel). 2025; 13(12.
PMID: 39765914
PMC: 11673030.
DOI: 10.3390/antiox13121587.
Long Jr D, Chan M, Han M, Kamdar Z, Ma R, Tsai P
Cell Rep Med. 2024; 5(9):101699.
PMID: 39208801
PMC: 11528240.
DOI: 10.1016/j.xcrm.2024.101699.
Tang L, Xu H, Wu T, Wu W, Lu Y, Gu J
Discov Oncol. 2024; 15(1):111.
PMID: 38602556
PMC: 11009183.
DOI: 10.1007/s12672-024-00902-8.
Peifer-Weiss L, Al-Hasani H, Chadt A
Int J Mol Sci. 2024; 25(3).
PMID: 38339185
PMC: 10855711.
DOI: 10.3390/ijms25031910.
Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia.
Yonamine C, Michalani M, Moreira R, Machado U
Int J Mol Sci. 2023; 24(22).
PMID: 38003671
PMC: 10671460.
DOI: 10.3390/ijms242216480.
Genes possibly related to symbiosis in early life stages of Acropora tenuis inoculated with Symbiodinium microadriaticum.
Yoshioka Y, Chiu Y, Uchida T, Yamashita H, Suzuki G, Shinzato C
Commun Biol. 2023; 6(1):1027.
PMID: 37853100
PMC: 10584924.
DOI: 10.1038/s42003-023-05350-8.
Antidiabetic and antihyperlipidemic activities of . extract and the regulation of Akt phosphorylation, gluconeogenesis, and peroxisome proliferator-activated receptor α in streptozotocin-induced diabetic mice.
Huang S, Lin C, Chang W, Shih C
Food Nutr Res. 2023; 67.
PMID: 37850072
PMC: 10578056.
DOI: 10.29219/fnr.v67.9854.
GLUT5: structure, functions, diseases and potential applications.
Song A, Mao Y, Wei H
Acta Biochim Biophys Sin (Shanghai). 2023; 55(10):1519-1538.
PMID: 37674366
PMC: 10582729.
DOI: 10.3724/abbs.2023158.
Energy metabolism and maternal-fetal tolerance working in decidualization.
Meng X, Chen C, Qian J, Cui L, Wang S
Front Immunol. 2023; 14:1203719.
PMID: 37404833
PMC: 10315848.
DOI: 10.3389/fimmu.2023.1203719.
BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
Wang P, Sun J, Sun C, Zhao H, Zhang Y, Chen J
Cancer Biol Ther. 2023; 24(1):2225884.
PMID: 37382415
PMC: 10312033.
DOI: 10.1080/15384047.2023.2225884.
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets.
You M, Xie Z, Zhang N, Zhang Y, Xiao D, Liu S
Signal Transduct Target Ther. 2023; 8(1):196.
PMID: 37164974
PMC: 10172373.
DOI: 10.1038/s41392-023-01442-3.
Metabolic Phenotype Intricacies on Altered Glucose Metabolism of Breast Cancer Cells upon Glut-1 Inhibition and Mimic Hypoxia In Vitro.
Littleflower A, Antony G, Parambil S, Subhadradevi L
Appl Biochem Biotechnol. 2023; 195(10):5838-5854.
PMID: 36708494
DOI: 10.1007/s12010-023-04373-5.
An appraisal of the current status of inhibition of glucose transporters as an emerging antineoplastic approach: Promising potential of new pan-GLUT inhibitors.
Temre M, Kumar A, Singh S
Front Pharmacol. 2022; 13:1035510.
PMID: 36386187
PMC: 9663470.
DOI: 10.3389/fphar.2022.1035510.
Inositol supplementation and body mass index: A systematic review and meta-analysis of randomized clinical trials.
Zarezadeh M, Dehghani A, Faghfouri A, Radkhah N, Naemi Kermanshahi M, Hamedi Kalajahi F
Obes Sci Pract. 2022; 8(3):387-397.
PMID: 35664247
PMC: 9159559.
DOI: 10.1002/osp4.569.
Metabolic Shades of S-D-Lactoylglutathione.
Kalapos M, Antognelli C, de Bari L
Antioxidants (Basel). 2022; 11(5).
PMID: 35624868
PMC: 9138017.
DOI: 10.3390/antiox11051005.
miRNA-199a-5p/SLC2A1 axis regulates glucose metabolism in non-small cell lung cancer.
Xu Y, Chai B, Wang X, Wu Z, Gu Z, Liu X
J Cancer. 2022; 13(7):2352-2361.
PMID: 35517408
PMC: 9066207.
DOI: 10.7150/jca.67990.
SLC2A3 variants in familial and sporadic congenital heart diseases in a Chinese Yunnan population.
Ma L, Xu J, Tang Q, Cao Y, Kong R, Li K
J Clin Lab Anal. 2022; 36(6):e24456.
PMID: 35466476
PMC: 9169219.
DOI: 10.1002/jcla.24456.
Towards Selective Binding to the GLUT5 Transporter: Synthesis, Molecular Dynamics and In Vitro Evaluation of Novel C-3-Modified 2,5-Anhydro-D-mannitol Analogs.
Rana N, Aziz M, Oraby A, Wuest M, Dufour J, Abouzid K
Pharmaceutics. 2022; 14(4).
PMID: 35456662
PMC: 9032776.
DOI: 10.3390/pharmaceutics14040828.
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection.
Griffante G, Hewelt-Belka W, Albano C, Gugliesi F, Pasquero S, Castillo Pacheco S
mBio. 2022; 13(3):e0043522.
PMID: 35420480
PMC: 9239058.
DOI: 10.1128/mbio.00435-22.
